Khaista Rahman , Muhammad Jamal , Xi Chen , Wei Zhou , Bin Yang , Yanyan Zou , Weize Xu , Yingying Lei , Chengchao Wu , Xiaojian Cao , Rohit Tyagi , Muhammad Ahsan Naeem , Da Lin , Zeshan Habib , Nan Peng , Zhen F. Fu , Gang Cao
{"title":"Reprogramming Mycobacterium tuberculosis CRISPR System for Gene Editing and Genome-wide RNA Interference Screening","authors":"Khaista Rahman , Muhammad Jamal , Xi Chen , Wei Zhou , Bin Yang , Yanyan Zou , Weize Xu , Yingying Lei , Chengchao Wu , Xiaojian Cao , Rohit Tyagi , Muhammad Ahsan Naeem , Da Lin , Zeshan Habib , Nan Peng , Zhen F. Fu , Gang Cao","doi":"10.1016/j.gpb.2021.01.008","DOIUrl":null,"url":null,"abstract":"<div><p><strong><em>Mycobacterium tuberculosis</em></strong> is the causative agent of tuberculosis (TB), which is still the leading cause of mortality from a single infectious disease worldwide. The development of novel anti-TB drugs and vaccines is severely hampered by the complicated and time-consuming genetic manipulation techniques for <em>M. tuberculosis.</em> Here, we harnessed an endogenous type III-A CRISPR/Cas10 system of <em>M. tuberculosis</em> for efficient <strong>gene editing</strong> and RNA interference (RNAi). This simple and easy method only needs to transform a single mini-CRISPR array plasmid, thus avoiding the introduction of exogenous protein and minimizing proteotoxicity. We demonstrated that <em>M. tuberculosis</em> genes can be efficiently and specifically knocked in/out by this system as confirmed by DNA high-throughput sequencing. This system was further applied to single- and multiple-gene RNAi. Moreover, we successfully performed <strong>genome-wide RNAi screening</strong> to identify <em>M. tuberculosis</em> genes regulating <em>in vitro</em> and intracellular growth. This system can be extensively used for exploring the functional genomics of <em>M. tuberculosis</em> and facilitate the development of novel anti-TB drugs and vaccines.</p></div>","PeriodicalId":12528,"journal":{"name":"Genomics, Proteomics & Bioinformatics","volume":"20 6","pages":"Pages 1180-1196"},"PeriodicalIF":11.5000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225669/pdf/","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genomics, Proteomics & Bioinformatics","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1672022921002497","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 6
Abstract
Mycobacterium tuberculosis is the causative agent of tuberculosis (TB), which is still the leading cause of mortality from a single infectious disease worldwide. The development of novel anti-TB drugs and vaccines is severely hampered by the complicated and time-consuming genetic manipulation techniques for M. tuberculosis. Here, we harnessed an endogenous type III-A CRISPR/Cas10 system of M. tuberculosis for efficient gene editing and RNA interference (RNAi). This simple and easy method only needs to transform a single mini-CRISPR array plasmid, thus avoiding the introduction of exogenous protein and minimizing proteotoxicity. We demonstrated that M. tuberculosis genes can be efficiently and specifically knocked in/out by this system as confirmed by DNA high-throughput sequencing. This system was further applied to single- and multiple-gene RNAi. Moreover, we successfully performed genome-wide RNAi screening to identify M. tuberculosis genes regulating in vitro and intracellular growth. This system can be extensively used for exploring the functional genomics of M. tuberculosis and facilitate the development of novel anti-TB drugs and vaccines.
期刊介绍:
Genomics, Proteomics and Bioinformatics (GPB) is the official journal of the Beijing Institute of Genomics, Chinese Academy of Sciences / China National Center for Bioinformation and Genetics Society of China. It aims to disseminate new developments in the field of omics and bioinformatics, publish high-quality discoveries quickly, and promote open access and online publication. GPB welcomes submissions in all areas of life science, biology, and biomedicine, with a focus on large data acquisition, analysis, and curation. Manuscripts covering omics and related bioinformatics topics are particularly encouraged. GPB is indexed/abstracted by PubMed/MEDLINE, PubMed Central, Scopus, BIOSIS Previews, Chemical Abstracts, CSCD, among others.